Brexit Won’t Delay Drug Approvals, EMA’s Rasi Reassures Industry
Executive Summary
The EU’s centralized drug approval process will not be disrupted regardless of the number of employees the European Medicines Agency might lose when it relocates from London to Amsterdam, Guido Rasi pledged yesterday at the DIA Europe 2018 conference.